OVERLAND PARK, Kan.- Vince & Associates Clinical Research, a provider of comprehensive early development clinical research services for the global biopharmaceutical industry, broke ground on a new $5 million expansion of its research campus today.
Vince & Associates is recognized for its ability to rapidly and effectively recruit and retain both special patient populations and healthy normal volunteers in early phase clinical trials. The new building will house an expanded Recruitment Center which will support the demand for qualified subjects as well as benefit clients by further enhancing our organization’s ability to recruit and execute early development clinical trials.
“Our effective recruitment and execution of complex early development trials stems from our extensive, therapeutically driven database. By consistently meeting our clients’ enrollment milestones we are able to reliably provide early efficacy data for our clients’ drug development decisions,” said Dr. Brad Vince, CEO & Medical Director of Vince & Associates Clinical Research.
Included in this new three-story building is an advanced medical/surgical suite to conduct specialized clinical trial procedures such as endoscopies, biopsies and EEGs as well as house luxuriously designed research suites ideal for volunteers participating in overnight clinical trials.
A new, state-of-the-art pharmacy will provide additional depth for the extensive drug preparation methods conducted at Vince & Associates and will include an expanded USP 797 certified clean room which will exceed standards by maintaining an ISO Class V environment.
“The construction of this new three-story building will allow us to keep pace with demand from our biopharmaceutical clients as well as provide a clear, strategic advantage for Vince & Associates in the successful completion of complex clinical trials,” Dr. Vince said.